Comparing fingerprick and venous blood for monitoring tacrolimus levels in kidney transplant patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to compare the effectiveness of fingerprick blood samples versus traditional venous blood samples for monitoring tacrolimus levels in kidney transplant patients. Tacrolimus is an essential immunosuppressant medication that requires careful dosage monitoring to prevent organ rejection and complications. The study will involve patients attending the renal clinic at Nottingham University Hospitals NHS Trust who are currently receiving tacrolimus treatment. Blood samples will be analyzed to determine if the fingerprick method can provide comparable results to the venous method, potentially improving patient convenience and reducing the need for hospital visits.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients attending renal clinic who are receiving immunosuppressant treatment (tacrolimus) and require regular monitoring.

Exclusion Criteria:

* No exclusion criteria

Where it's running

• Nottingham University Hospitals NHS Trust
  Nottingham, United Kingdom Recruiting

Study contacts

• Principal investigator: Donna M Fullerton, PhD, FRCPath — Nottingham University Hospitals NHS Trust
• Study coordinator: Alison Lloyd
• Email: researchsponsor@nuh.nhs.uk
• Phone: 0115 924 9924

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Thymalfasin added to standard care for adults with sepsis and immune dysfunction

  This study tests whether thymosin alpha-1 helps restore immune function in adults with sepsis who have weakened immunity.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07866118

• Metabolic and Functional Study of γδ T Cells in Critically Ill Patients

  Researchers will look at how γδ T cells behave in severely ill patients, including those with sepsis, to see how their metabolism and function change.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Outside of the US · NCT07680816

• Using FibroScan to guide lowering immune-suppressing drugs after liver transplant

  This will test whether using FibroScan to measure liver stiffness lets doctors safely reduce immunosuppressive drugs in adults at least 2 years after a liver transplant who don't have autoimmune liver disease or recent rejection.

  Recruiting University of Alberta · Edmonton, Alberta · NCT07206277

• Preemptive genetic testing to guide tacrolimus treatment for kidney transplant patients

  This study will test whether doing a genetic test before transplant to guide tacrolimus dosing helps people on the kidney transplant waiting list stay safer and use health resources more efficiently.

  Recruiting Phase 4 Instituto de Investigación Hospital Universitario La Paz · Madrid, Madrid · NCT06701825

• Monitoring vaccine responses in immune compromised patients

  This study is trying to see how well vaccines work and how safe they are for people with weakened immune systems.

  Recruiting Pediatric Clinical Research Platform · Geneva · NCT06463119

• Once-daily tacrolimus regimens during the first year after liver transplant

  This will try once-daily tacrolimus with mycophenolate to see if simpler dosing helps people take their medicines and protects the transplanted liver during the first year after a liver transplant.

  Recruiting at 17 sites Phase 4 University Hospital, Limoges · Besançon and 17 other locations · NCT06354179

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.